11.23
price down icon5.23%   -0.62
after-market Handel nachbörslich: 11.25 0.02 +0.18%
loading

Ocular Therapeutix Inc Aktie (OCUL) Neueste Nachrichten

pulisher
Oct 14, 2025

Why analysts upgrade Ocular Therapeutix Inc. stock2025 Market Sentiment & Expert Verified Movement Alerts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How institutional ownership impacts Ocular Therapeutix Inc. stockJuly 2025 Momentum & Weekly Stock Performance Updates - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Analyzing drawdowns of Ocular Therapeutix Inc. with statistical toolsJuly 2025 Selloffs & Safe Entry Point Identification - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Can Ocular Therapeutix Inc. stock maintain growth trajectoryJuly 2025 Retail & Weekly High Return Stock Opportunities - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How to recover losses in Ocular Therapeutix Inc. stockEarnings Trend Report & Daily Profit Maximizing Tips - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Is Ocular Therapeutix Inc. stock oversold or undervaluedEntry Point & High Conviction Buy Zone Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What momentum shifts mean for Ocular Therapeutix Inc.2025 Market Sentiment & Verified Technical Trade Signals - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Using Ichimoku Cloud for Ocular Therapeutix Inc. technicalsGap Down & Fast Moving Stock Watchlists - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Ocular Therapeutix Inc. stock trendline breakdownWall Street Watch & Expert Curated Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Real time pattern detection on Ocular Therapeutix Inc. stockWeekly Profit Recap & Reliable Volume Spike Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How risky is Ocular Therapeutix Inc. (0OT) stock compared to peersRecession Risk & Weekly Chart Analysis and Guides - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Ocular Therapeutix (OCUL): Assessing Valuation After Clinical Progress, Analyst Upgrades, and Major Fundraising - Sahm

Oct 12, 2025
pulisher
Oct 11, 2025

Todd Anderman Sells 11,132 Shares of Ocular Therapeutix (NASDAQ:OCUL) Stock - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

FY2025 EPS Estimate for Ocular Therapeutix Raised by Analyst - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

Ocular Therapeutix chief legal officer Anderman sells $137k in stock - Investing.com Canada

Oct 10, 2025
pulisher
Oct 10, 2025

How to track smart money flows in Ocular Therapeutix Inc.July 2025 Fed Impact & AI Driven Price Forecasts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using AI based signals to follow Ocular Therapeutix Inc.Earnings Recap Summary & Safe Investment Capital Preservation Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Ocular Therapeutix (NASDAQ:OCUL) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

What machine learning models say about Ocular Therapeutix Inc.IPO Watch & Trade Opportunity Analysis - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 03:24:04 - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using R and stats models for Ocular Therapeutix Inc. forecastingMarket Risk Analysis & Smart Allocation Stock Reports - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Is Ocular Therapeutix Inc. (0OT) stock considered safe haven2025 Market Outlook & Reliable Breakout Forecasts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Price action breakdown for Ocular Therapeutix Inc.2025 Retail Activity & Weekly Stock Breakout Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

WilmerHale Advised Ocular Therapeutix™ in $475 Million Underwritten Offering - WilmerHale

Oct 08, 2025
pulisher
Oct 08, 2025

HC Wainwright & Co. Maintains Ocular Therapeutix (OCUL) Buy Recommendation - Nasdaq

Oct 08, 2025
pulisher
Oct 08, 2025

Ocular Therapeutix (OCUL): HC Wainwright & Co. Raises Price Targ - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Piper Sandler Lifts PT on Ocular Therapeutix (OCUL) to $31 From $21 - Yahoo Finance

Oct 08, 2025
pulisher
Oct 07, 2025

Ocular Therapeutix, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 07, 2025
pulisher
Oct 07, 2025

Ocular Therapeutix (OCUL) Falls Hard on $475-Million Share Sale - MSN

Oct 07, 2025
pulisher
Oct 07, 2025

Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences - GlobeNewswire

Oct 07, 2025
pulisher
Oct 06, 2025

Ocular Therapeutix (NASDAQ:OCUL) Insider Sells $106,472.59 in Stock - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Ocular Therapeutix (NASDAQ:OCUL) Insider Jeffrey Heier Sells 10,502 Shares - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

What analysts say about Ocular Therapeutix Inc stockGap Up/Gap Down Analysis & Free Rapid Wealth Building - earlytimes.in

Oct 06, 2025
pulisher
Oct 06, 2025

Why Ocular Therapeutix Inc. (0OT) stock is trending on social mediaLong Setup & Technical Pattern Alert System - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Ocular Therapeutix (OCUL) Is Down 8.9% After $475M Equity Raise to Fund Axpaxli Trials — Has the Bull Case Changed? - Sahm

Oct 05, 2025
pulisher
Oct 05, 2025

Exit strategy if you’re trapped in Ocular Therapeutix Inc.July 2025 Summary & Long-Term Growth Portfolio Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will Ocular Therapeutix Inc. stock deliver long term returns2025 Momentum Check & Technical Pattern Recognition Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 03:10:01 - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Looking at the Changing Narrative for Ocular Therapeutix After Recent Analyst Updates - Yahoo Finance

Oct 04, 2025
pulisher
Oct 04, 2025

Ocular Therapeutix (NASDAQ:OCUL) Stock Rating Upgraded by Zacks Research - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Ocular Therapeutix (OCUL): Exploring Valuation as Investor Interest Grows in Biotech Prospects - Sahm

Oct 03, 2025
pulisher
Oct 03, 2025

Ocular Therapeutix (OCUL) Analyst Rating Update: Piper Sandler Raises Price Target | OCUL Stock News - GuruFocus

Oct 03, 2025
pulisher
Oct 03, 2025

Ocular Therapeutix (OCUL) Receives Upgraded Price Target from Ba - GuruFocus

Oct 03, 2025
pulisher
Oct 03, 2025

Baird Maintains Ocular Therapeutix (OCUL) Outperform Recommendation - Nasdaq

Oct 03, 2025
pulisher
Oct 02, 2025

Published on: 2025-10-02 20:18:07 - newser.com

Oct 02, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):